logo
3D Sensing & AI Give Operatic Voice To Non-Verbal Performers

3D Sensing & AI Give Operatic Voice To Non-Verbal Performers

Forbes9 hours ago

MELBOURNE, AUSTRALIA - JULY 26: Anthony Warlow and Ana Marina, cast members of The Phantom of the ... More Opera perform on stage at the photo call for the new production of Broadway's longest running musical "The Phantom of the Opera" at the Princess Theatre on July 25, 2007 in Melbourne, Australia. (Photo by)
Ever wonder what it takes to deliver an opera performance that is historic in terms of longevity, quality and audience numbers? Talented performers, money, advertising, writing, music, etc. It is a process that has been followed for more than a century, and is fairly predictable and linear.
Now imaging what it takes to deliver an opera performance about a mother and her non-verbal, non-ambulatory son? With a cast composed of predominantly disabled performers, many with impaired or limited speech? Dedication, time, focus, persistence, creativity, technology, philanthropic support, vision AND innovation. Over a 7 year period, librettist Brenda Shaughnessy and composer Paola Prestini, directed by Jerron Herman and Jay Scheib, created Sensorium Ex, culminating in a premier performance in Omaha, Nebraska in May 2025. It fuses 3D sensing, artificial intelligence, disability solutions, operatic talent and artistic creativity to deliver a groundbreaking performance.
Dr. Luke Dubois is the Associate Professor of Integrated Design & Media (IDM) and Co-Director of the Technology, Culture and Society Department at New York University's Tandon School of Engineering. This is the only department in the country that is part of an engineering school AND accredited by the National Academy of Design. He is also the Co-Director of the Ability Project, a joint research initiative with the Occupational Therapy Department (NYU Steinhardt) and the Interactive Telecommunications Program (NYU Tisch). It supports research in assistive technology and adaptive design for people with disabilities. Dr. Dubois has a Ph.D. in music and a strong background in electronics, speech synthesizers and solutions that fuse art, engineering and design. His laboratory/office at NYU Tandon is reminiscent of a music studio where you can easily imagine legendary bands like Pink Floyd, Led Zeppelin, Jethro Tull and the Boss recording (Disclosure: I am a fan).
Figure 1: Luke Dubois in Lab, DIY (Do It Yourself) Kit Built Synthesizers, Historic Guitars
Speech synthesizers as human aids (also called AAC or Augmentative & Alternative Communication devices) were originally invented by Ray Kurzweil in 1975. They used OCR (Optical Character Recognition) to assist the blind or visually impaired to 'Listen' to written text. The next evolution in this technology occurred with Intel and Stephen Hawking who used keyboard text input input and eye/gaze movement to communicate via a speech synthesizer. It worked and helped at the time, but the output was, well, robotic. This is a problem for something like the opera where nuance, emotion and artist personalization are key attributes (based on a survey of ~40 such artists). Dr. Dubois' collaboration with Sensorium Ex started 5 years ago, with a request from Paola Prestini to develop the technology to enable speech challenged artists to perform in the opera.
Solution Strategy: Dr. Dubois and his team came up with a two-step process:
1. Personalizing Speech Using AI: some people with cerebral palsy have a condition called apraxia, in which the person mentally feels that they are speaking normally, although it vocalizes as jumbled speech. Using a combination of speech editing software (ProMoNet) and a neural vocoder, these sounds can be transformed into coherent speech (but still robotic). NJIT (New Jersey Institute of Technology) Professor Mark Cartwright uses these tools in conjunction with machine learning and AI to inject the individual's sound and speech characteristics. This humanizes and personalizes the robotic speech created by the ProMoNet and the neural vocoder tools.
2. Injecting Individual Creativity and Emotion into the Opera Performance: the challenge is to enable the performer to insert emotion, tempo, emphasis and vocal stretch. People affected by cerebral palsy have control of certain types of hand movement (some macro and others micro). Using their hands to control the different nuances of their operatic speech in real time is a challenge. Enter Eric Singer, a Brooklyn, NY based musician/engineer/entrepreneur, self proclaimed mad scientist and owner of Singertronics. He designed and built the Ther'minator (Figure 2), which transforms LiDAR (Light Detection and Ranging) sensing signals into modular voltages (between 0-5 volts), and transmits it using WiFi. The name is a spin on the Theremin, an electronic musical instrument controlled without physical contact by the performer.
Figure 2: Therm'nator Time of Flight Sensor (Center area is the STMIcro VL53 LiDAR Chip)
Ther'minator uses very low cost (< $10) Model VL 53 Time of Flight (ToF) sensors from STMicro . These sensors are composed of 940 nm SPADs (Single Photon Avalanche Detectors) and VCSELs (Vertical Cavity Surface Emitting Laser), integrated with optical noise filters, short pulse laser drivers and readout electronics. Their performance is suitable for short range 3D sensing (< 5 m), and typically used in automobile airbags to sense human presence. Higher power versions are used in smart phones.
Lets Omaha: Using a combination of three Ther'minator units, with other electronics for power and signal processing converts the performer's hand movements into output electrical signals (see Figure 3). This board was designed by Andrea Lauer, the production designer for Sensorium Ex.
Figure 3: Sensor and Electronics Board for Sensorium AI Voice Control Showing 3 Ther'minators
The signals are fed into a computer that integrates the LiDAR output voltages with the performer's personalized speech (through the AI trained algorithm discussed earlier). A calibration is performed for each individual since arm movements and their correlation with the performer's vocal intent vary.
Figures 4 shows Jakob Jordan (playing the lead role of the son, Kitsune, in Sensorium Ex) practicing with the sensor board and in dress rehearsals.
Figure 4: LEFT: Performer Jakob Jordan Practicing with the Ther'minator Board at the Sensorium Ex ... More Production Residency, April 2025; RIGHT: Sensorium Ex dress rehearsal at Sapp Fieldhouse 5-20-25
The Omaha premier held 4 shows with about 150-200 attendees in each. Seating was configured to accommodate a spectrum of disability conditions. Paola Prestini, the composer of Sensorium Ex, also leads National Sawdust and Vision Into Art, both non-profit organizations dedicated to promoting and supporting art across various genres of performers (Vision Into Art sponsored Sensorium Ex). I spoke to her about the 7 year journey for Sensorum Ex.
Future Directions
This effort is a monumental disruption in the fusion of art and technology. How will it impact speech-challenged artists in the future? Will mainstream productions like the Phantom of the Opera or Hamilton incorporate such talent in their productions, with higher levels of assistive performance enhancements? Can the technology demonstrated here be extended to other quality of life enhancements like physical therapy and rehabilitation? A few thoughts:
Using technology for assisting physically challenged individuals is an accelerating trend. Robotics, 3D sensing, AI, speech enhancement and movement automation technologies can dramatically elevate quality of life for all humanity.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

/R E P E A T -- Media advisory - Minister Joly to hold a virtual media availability at the Paris Air Show/
/R E P E A T -- Media advisory - Minister Joly to hold a virtual media availability at the Paris Air Show/

Yahoo

timean hour ago

  • Yahoo

/R E P E A T -- Media advisory - Minister Joly to hold a virtual media availability at the Paris Air Show/

PARIS, June 16, 2025 /CNW/ - The Honourable Mélanie Joly, Minister of Industry and Minister responsible for Canada Economic Development for Quebec Regions, is participating in the International Paris Air Show at Le Bourget in Paris, France, from June 16 to 17. The Minister met with key industry stakeholders in the aerospace, space and defence sectors to highlight Canada's innovative aerospace industry and promote Canada as a top destination for aerospace investment from around the world. Date: Tuesday, June 17, 2025 Time: 3:15 pm (CET) / 9:15 am (ET) Location: virtual This event is for accredited members of the Press Gallery only. Media who are not members of the Press Gallery may contact pressres2@ for temporary access. Stay connected Find more services and information on the Innovation, Science and Economic Development Canada website. Follow Innovation, Science and Economic Development Canada on social media.X (Twitter): @ISED_CA | Facebook: Canadian Innovation | Instagram: @cdninnovation | LinkedIn: Innovation, Science and Economic Development Canada SOURCE Innovation, Science and Economic Development Canada View original content: Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

'New pathway' to cure for HIV discovered using tech from COVID-19 vaccine
'New pathway' to cure for HIV discovered using tech from COVID-19 vaccine

Yahoo

time2 hours ago

  • Yahoo

'New pathway' to cure for HIV discovered using tech from COVID-19 vaccine

Researchers have taken a giant leap in the search for an HIV cure by discovering a way to identify the virus even as it is camouflaged among other cells. HIV spreads by invading and multiplying within white blood cells, which fight disease and infection. One of the main roadblocks in developing a cure has been finding a way to isolate and kill the virus without also killing white blood cells and harming the body's immune system. Researchers from the Peter Doherty Institute for Infection and Immunity in Melbourne, Australia have now cultivated a method to identify the virus among white blood cells, as demonstrated in a recent paper published in Nature Communications, isolating the virus for potential treatment. The technology involves mRNA — molecules isolated from DNA that can teach the body how to make a specific protein — which were also used in the COVID-19 vaccines. By introducing mRNA to white blood cells, it can force the cells to reveal the virus. Using mRNA in this way was 'previously thought impossible,' research fellow at the Doherty Institute and co-first author of the study Paula Cevaal told The Guardian, but the new development "could be a new pathway to an HIV cure.' 'In the field of biomedicine, many things eventually don't make it into the clinic – that is the unfortunate truth; I don't want to paint a prettier picture than what is the reality,' Cevaal said. 'But in terms of specifically the field of HIV cure, we have never seen anything close to as good as what we are seeing, in terms of how well we are able to reveal this virus. A cure is still years away, as Cevaal said it would still need to be tested on animals and then humans to see if it can be done safely on living beings before they can test whether or not a potential treatment would even work. However, she added that that "we're very hopeful that we are also able to see this type of response in an animal, and that we could eventually do this in humans.'

The UK Must Bridge Funding Gaps To Position Itself As Hub For R&D
The UK Must Bridge Funding Gaps To Position Itself As Hub For R&D

Forbes

time2 hours ago

  • Forbes

The UK Must Bridge Funding Gaps To Position Itself As Hub For R&D

Innovation needs a new safe haven and while the UK has all the building blocks to be that place, to make it happen we need to ensure that our ambition translates into delivery. The UK's latest research and development funding settlement has reignited a familiar tension of long-term ambition versus short-term constraint. CaSE has cautioned that the government's £8.8 billion funding allocation to UK Research and Innovation (UKRI) essentially amounts to a flat-cash settlement. Along with inflation and rising operating costs this means less room for new investment – forcing harder choices at a time when our ambitions to become a global hotspot for science depend on sustained momentum. The recent announcement of 10-year budgets for R&D funding is a welcome signal of long-term intent and offers a degree of clarity that industry and academia alike have long called for. However, visibility alone is not the same as increased investment. Unless these budgets translate into real-terms growth, the UK risks falling behind its global competitors. However, disruption in the global R&D landscape and notably the US, presents an opportunity. If we act swiftly and work strategically, the UK can position itself as a stable, globally attractive home for international talent and industry investment. But this must be matched by real-world readiness. Preparing for change In the US, proposals to significantly reduce budgets for key agencies like the National Institute of Health and National Science Foundation have raised alarm. Coupled with a rise in anti-vaccine rhetoric and scientists facing budget-cuts overnight, we're seeing an environment emerge that may stifle talent rather than nurture it. I – and many others – will also be keeping an ear to the ground as we continue to await a decision around pharma tariffs. While we're not expecting a mass exodus out of the US, it would be naïve to think that in this climate, talent couldn't be tempted elsewhere. To attract these internationally mobile innovators, tech entrepreneurs, engineers and scientists, we need to prove that the welcome mat is out, and the funding tap is on. That's where innovation clusters can play a vital role. Back in 2021, QIAGEN, a global diagnostics company from Germany, established its Global Centre of Excellence for Precision Medicine at Bruntwood SciTech's Citylabs 2.0, where it now actively partners with the NHS to accelerate healthcare breakthroughs. More recently, US pharmaceutical giant Eli Lilly began a five-year trial into the effectiveness of weight loss drug Tirzepatide on the job prospects of people living with obesity in Greater Manchester. The trial is being run by Health Innovation Manchester in partnership with Eli Lilly, along with the University of Manchester and local digital trials company NorthWest EHealth. And at a time when commercial clinical trial recruitment is in decline, Greater Manchester is bucking the trend, driven by a good relationship with the patient population, strong research infrastructure, a talented workforce and collaboration between providers, businesses, academia and industry. That is to say, while the national funding picture remains tight, we're seeing regional hubs across the UK stepping up. Regional strength equals international advantage A well-known challenge for new start-ups, especially within technology and innovation, is attracting early-stage investment. We need to see improved funding in areas away from the more traditional locations of London and South East England, that can attract young companies and new talent – both nationally and internationally. As such, we welcome the Government's latest commitment to provide £500 million for regions across the UK to make decisions around how to boost R&D in a way that is most appropriate for them. Innovation hubs in cities like Manchester, Birmingham and Leeds are helping to maintain momentum despite national funding pressures. These places are building internationally connected clusters underpinned by strong partnerships between academia, industry and the public sector. In Manchester, for example, the recently opened Citylabs 4.0 provides new specialist lab and office space on Europe's largest clinical-academic campus, supporting life sciences research and strengthening collaboration with the NHS. Meanwhile, in Leeds, a wave of activity is strengthening the city's profile as a destination for innovative, high-growth businesses. Iconic British broadcaster Channel 4, Yorkshire Bank and international energy and services company Centrica all have significant operations in the city, attracted by its growing financial services cluster, collaborative tech ecosystem and access to skilled talent. However, we're seeing competition across the EU to attract internationally mobile talent and businesses in the sector. The European Commission recently unveiled its 'Choose Europe' scheme to promote the region as a world-leading centre of research, innovation and scientific freedom – including a €500 million pledge for 2025-27, to make Europe a 'magnet' for researchers. To draw top-tier talent and investment then, we need to double-down on what makes the UK standout. That is, openness to collaboration, strength in diversity of research and a unique blend of regionally driven infrastructure and ecosystem support. The government's commitment to UKRI is a signal of ambition but flat cash won't be enough to stay ahead. If we're serious about being a superpower of tech, innovation and science, now is the time to act. That means ensuring real-term investment to support our regional powerhouses and showing the world that we are the most attractive, stable home for the next generation of global innovation.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store